#Sweden #Stockholm #Women's Health #Iron Deficiency #Probi

Biotic Innovation Addressing Iron Deficiency in Women

In recent times, a groundbreaking health solution has emerged, specifically designed to enhance iron absorption in women. This innovation has garnered international accolades, receiving prestigious awards in Europe, North America, and now Asia. The recognition across three continents in 2025 underscores the growing awareness of the urgent need for more effective and well-tolerated iron supplementation.

Developed by Probi, a pioneer in biotic solutions, this concept revolves around the clinically studied probiotic strain, Lactiplantibacillus plantarum 299v (LP299V®). When combined with iron, LP299V® not only enhances the body's ability to absorb iron but also minimizes the gastrointestinal side effects commonly associated with traditional iron supplements.

Iron deficiency stands out as one of the most pressing nutritional issues globally, with over 30% of women of childbearing age affected. Instead of merely adding iron to diet, Probi’s patented strain assists the body in absorbing it more effectively. The LP299V® strain promotes iron assimilation in two crucial ways: maintaining iron in its absorbable form and enhancing the expression of iron-converting enzymes within the body. This dual action leads to significantly improved absorption from both food and supplements.

Martina Pettersson, Probi’s global marketing director, commented on the recognition the innovation has received, stating, "The acknowledgment across three continents in a single year highlights the urgent and global nature of this issue, as well as the promise of scientifically supported biotic innovations in addressing it." The latest accolade, the 2025 NutraIngredients-Asia Award for Innovation in Women’s Health, was awarded in Bangkok on September 17, following previous awards in Europe and North America.

Karen Ong, Probi’s Asia-Pacific regional manager, emphasized the importance of this innovation, stating, "This solution plays a crucial role in Asia, where iron deficiency continues to affect millions of women. This demonstrates how accessible and well-tolerated solutions can create a significant difference.”

The LP299V® strain has been researched for over 30 years. Initially recognized for its digestive benefits, it is increasingly acknowledged for its unique ability to enhance iron absorption, thus contributing to women’s health improvements worldwide.

About Probi

Probi® is a globally recognized biotic solutions company focusing on the research, manufacturing, and distribution of biotic products for dietary supplements and functional foods. With a scientific basis, Probi is committed to collaborating with clients and research partners to envision a future where as many people as possible can take control of their gut microbiome for better and longer lives. Founded in 1991 at Lund University in Sweden, Probi has expanded to serve over 40 markets worldwide and holds numerous global patents. Since 2025, Probi has been part of Symrise AG, further enhancing its innovation capabilities and global reach.